Novo Integrated Sciences, Inc. (NVOS) Financial Statements
Novo Integrated Sciences, Inc. (NVOS) files with the U.S. Securities and Exchange Commission under CIK 0001138978. 10KGenie shows its annual and quarterly statements from SEC filings.
Key Figures, Fiscal Year 2024
- Revenue
- $13.29 million
- Net Income
- -$16.17 million
- Total Assets
- $32.14 million
- Net Cash from Operations
- -$5.07 million
Fiscal year ended Aug 31, 2024. Latest periodic SEC filing: Dec 18, 2024. Source: SEC filings (EDGAR XBRL).
Open the full financial statements for NVOS in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History